Celebrities like Chelsea Handler and Dolores Catania have touted Semaglutide®, sold under the brand name Ozempic®, as an effective weight loss solution. Although the FDA hasn’t officially approved it for this purpose, many doctors are prescribing it off-label, and research supports its effectiveness.
How Semaglutide® Works
Semaglutide® helps regulate hunger by mimicking the hormone GLP-1, which promotes feelings of fullness. Unlike older weight loss medications that focused on fat absorption, semaglutide targets hunger hormones directly. Many users report feeling satisfied with smaller portions and experiencing fewer cravings.
Effectiveness of Semaglutide®
Studies have shown impressive weight loss results with Semaglutide®. For example, one study indicated that participants lost nearly 16% of their body weight over 16 months, while another found an average loss of 14.9% over 68 weeks.
In addition to prescription Semaglutide®, some patients are exploring compounded Semaglutide®, which is tailored by pharmacies to meet individual needs. While there’s limited research on the efficacy of compounded versions compared to FDA-approved options, they may provide an alternative for those seeking personalized treatment.
Who Should Consider Semaglutide®?
Semaglutide® is primarily used for diabetes management, but it has FDA approval for weight loss under the name Wegovy® for individuals with a BMI over 30 or a BMI of 27 with other weight-related health conditions. However, it’s important to maintain a healthy lifestyle, as medication alone cannot replace the benefits of a balanced diet and regular exercise.
If you're considering Semaglutide® for weight loss, consult with a healthcare provider to determine if it’s right for you.
